Cleared Traditional

K181823 - KardiaAI

K181823 is an FDA 510(k) clearance for KardiaAI, manufactured by AliveCor, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 245-day FDA review.

K181823 · AliveCor, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
245d
Days
Class 2
Risk

K181823 is an FDA 510(k) clearance for the KardiaAI. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by AliveCor, Inc. (Mountain View, US). The FDA issued a Cleared decision on March 11, 2019 after a review of 245 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all AliveCor, Inc. devices

FDA 510(k) Submission Details - K181823

510(k) Number K181823 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 09, 2018
Decision Date March 11, 2019
Days to Decision 245 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
120d slower than avg
Panel avg: 125d · This submission: 245d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 268
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K181823.
VIVO
K183195 · Catheter Precision, Inc. · Jun 2019
Edwards Pressure Cable
K191089 · Edwards Lifesciences, LLC · Jun 2019
AcQMap High Resolution Imaging and Mapping System
K190131 · Acutus Medical, Inc. · Apr 2019
RhythmAnalytics
K182344 · Biofourmis Singapore Pte., Ltd. · Mar 2019
EP-TRACER System
K183266 · Schwarzer Cardiotek GmbH · Mar 2019
QUANTIEN Measurement System
K183099 · St. Jude Medical (Now Abbott Medical) · Feb 2019